Unit:
Administrative Committee of Meizhou North Bank Economic Development Zone
Project Area:
putian Mazu Health City; Cross-Strait Biotech Industrial Park
Industry:
Biological and New Pharmaceutical Industry
Type of Project:
New Project
Cooperation Mode:
Collaborate
Nature of Project:
Encourage
Working Progress in Prior Period:
none
Total Investment:
discussed in detai
Expected to Attract Investment:
discussed in detai
Benefit Analysis:
none
Reason and Condition:
none
Content and Scale:
1. Mazu Health City: It mainly introduces specialized clinical hospitals, departments of high-end medical technologies, cutting-edge diagnostic treatment technology centers, hospitals, eldercare and health management institutions, medical testing institutions, and high-level medical specialty R&D teams.2. Cross-Strait Biotech Industrial Park: It mainly introduces production and sales projects of natural medicines, active pharmaceutical ingredients and preparations; production, operation and sales projects of medical devices; processing, production and trade projects of health products, food for special medical purposes (FSMP), cosmetics, and beauty devices, as well as a medical equipment exhibition center.
Others:
none
Industry

Biological & New Pharmaceutical Industry

In 2024, Fujian Province had 344 pharmaceutical enterprises above designated size, generating a total revenue of RMB 60.84 billion. Our province has established a relatively comprehensive pharmaceutical industrial system, covering categories such as chemical APIs (active pharmaceutical ingredients), chemical drug preparations, biopharmaceuticals, traditional Chinese medicine (TCM) preparations, TCM decoction pieces, and medical devices. The biopharmaceutical industry in Fujian Province is primarily concentrated in Xiamen, Sanming, Fuzhou, and Zhangzhou, with these four cities accounting for approximately 80% of our province's total revenue.